{"DataElement":{"publicId":"3227883","version":"1","preferredName":"Patient Brain Lesion Clinical Trial Eligibility Criteria Ind-2","preferredDefinition":"the yes/no indicator related to an area of abnormal tissue change in the brain as an element of the personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"3227879v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3227879","version":"1","preferredName":"Patient Brain Lesion Clinical Trial Eligibility Criteria","preferredDefinition":"information related to an area of abnormal tissue change in the brain as an element of the personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"2177068v1.0:3227877v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3227877","version":"1","preferredName":"Brain Lesion Clinical Trial Eligibility Criteria","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.:(LEE-zhun) An area of abnormal tissue change.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C12439:C3824:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E73EC1-D9E6-49E4-E040-BB89AD434678","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"ONEDATA","dateModified":"2011-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E73EC1-D9F7-49E4-E040-BB89AD434678","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"3227879v1.0:2018257v1.0","type":"USED_BY","context":"CTEP"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"3227879v1.0:2018257v1.0","type":"USED_BY","context":"COG"},{"name":"BRN_LSN_IND","type":"OID, COG","context":"COG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"BRAIN_METS_SIZE_ELIG","type":"OID, NRG","context":"NRG"}],"ReferenceDocuments":[{"name":"Any unresected lesions must m","type":"Preferred Question Text","description":"Any unresected lesions must measure <=3.0 cm in maximal extent on the contrasted preoperative treatment MRI brain scan obtained <=35 days prior to pre-registration (see Magnetic Resonance Imaging Guidelines, Section 11.2).  The unresected lesions will be treated with SRS as outlined in the treatment section (Section 7.0) of the protocol.","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Any unresected lesions must measure <=3.0 cm in maximal extent on the contrasted MRI brain scan obtained <=35 days prior to pre-registration (see Magnetic Resonance Imaging Guidelines, Section 11.2). The unresected lesions will be treated with SRS as outlined in the treatment section (Section 7.0) of the protocol.","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Does patient have an intrinsic brain stem tumors, optic pathway gliomas, or pineal tumors and elevations of CSF or serum tumor markers including alpha-fetoprotein or beta-HCG","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Any unresected lesions must measure <3.0 cm in maximal extent on the contrasted MRI or CT brain scan obtained <=35 days prior to pre-registration (see Magnetic Resonance Imaging Guidelines, Section 11.2). The unresected lesions will be treated with SRS as outlined in the treatment section (Section 7.4) of the protocol.","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_3","type":"Alternate Question Text","description":"Does patient have diffuse intrinsic pontine glioma","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Does patient have biopsy confirmed anaplastic astrocytoma, glioblastoma, gliosarcoma, or anaplastic mixed glioma","url":null,"context":"CTEP"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does patient have recurrent, progressive or refractory diffuse intrinsic pontine glioma (DIPG)?","url":null,"context":"PBTC"},{"name":"COG_CRF_TEXT_4","type":"Alternate Question Text","description":"Does patient have intrinsic brain stem tumors, optic pathway gliomas, indicated germ-cell tumors or elevations of serum tumor markers including alpha-fetoprotein or beta-HCG","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_5","type":"Alternate Question Text","description":"Does patient have intrinsic brain stem tumors, optic pathway gliomas, CNS germ cell tumors or extra-cranial germ cell tumors with elevations of CSF or serum tumor markers including alpha-fetoprotein or beta-HCG","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_6","type":"Alternate Question Text","description":"Does the patient have diffuse intrinsic pontine tumors as seen on MRI (greater than 2/3 of pons involvement on imaging)?","url":null,"context":"COG"},{"name":"NRG_CRF_TEXT1","type":"Alternate Question Text","description":"Do the distant brain relapse lesions to be treated measure less than or equal to 3.0 cm in maximal extent and the total volume measures less than 30 mL on the contrast-enhanced diagnostic MRI within 21 days prior to randomization?","url":null,"context":"NRG"},{"name":"NRG_CRF_TEXT2","type":"Alternate Question Text","description":"Does the lesion to be resected on the post-contrast MRI, as measured on any orthogonal plane (axial, sagittal, coronal), maximum diameter measure greater than or equal to 2.0 cm and less than or equal to 5.0 cm?","url":null,"context":"NRG"},{"name":"NRG_CRF_TEXT3","type":"Alternate Question Text","description":"At least 1 of the up to 8 lesions must be a study eligible lesion, defined as lesion with a maximum diameter as measured on any orthogonal plane (axial, sagittal, coronal)of greater than or equal to 1.0 cm and less than or equal to 3.0 cm","url":null,"context":"NRG"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A0E70059-1407-4D42-E040-BB89AD43681D","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"TYRRELLM","dateModified":"2024-01-04","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"01.04.2024 Added AQT and Alt Short Name per request ticket CADSR0003248_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}